157 related articles for article (PubMed ID: 22297037)
1. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function.
Raposeiras-Roubín S; Aguiar-Souto P; Barreiro-Pardal C; López Otero D; Elices Teja J; Ocaranza Sanchez R; Cid Alvarez B; Trillo Nouche R; Maceiras MV; Abu-Assi E; García-Acuña JM; González-Juanatey JR
Angiology; 2013 Jan; 64(1):31-9. PubMed ID: 22297037
[TBL] [Abstract][Full Text] [Related]
2. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
[TBL] [Abstract][Full Text] [Related]
3. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
4. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
6. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
[TBL] [Abstract][Full Text] [Related]
7. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
[TBL] [Abstract][Full Text] [Related]
10. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
12. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
[TBL] [Abstract][Full Text] [Related]
13. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
Liu YH; Jiang L; Duan CY; He PC; Liu Y; Tan N; Chen JY
Angiology; 2017 Oct; 68(9):782-789. PubMed ID: 28135823
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
16. Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome.
Raposeiras Roubín S; Abellas-Sequeiros RA; Abu Assi E; Yousef-Abumuaileq RR; Rodríguez Mañero M; Iglesias Álvarez D; González-Salvado V; González Ferreiro R; Redondo Diéguez A; Ocaranza Sánchez R; Virgós Lamela A; Peña Gil C; García Acuña JM; González Juanatey JR
Am J Cardiol; 2015 Mar; 115(5):587-91. PubMed ID: 25591897
[TBL] [Abstract][Full Text] [Related]
17. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
18. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Weisbord SD; Hartwig KC; Sonel AF; Fine MJ; Palevsky P
Catheter Cardiovasc Interv; 2008 Jun; 71(7):879-85. PubMed ID: 18412255
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of contrast-induced nephropathy in patients with myocardial infarction].
Kalaeva VV; Karetnikova VN; Osokina AV; Gruzdeva OV; Kashtalap VV; Evseeva MV; Bykova IS; Zykov MV; Shafranskaia KS; Barbarash OL
Klin Med (Mosk); 2014; 92(9):39-45. PubMed ID: 25790710
[TBL] [Abstract][Full Text] [Related]
20. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
